Results 31 to 40 of about 12,585 (215)

β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]

open access: yesPLoS ONE, 2014
Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça   +9 more
doaj   +1 more source

Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. [PDF]

open access: yesPLoS ONE, 2018
OBJECTIVE:To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN:Cross-sectional study.
José Marcos Sanches   +8 more
doaj   +1 more source

Clinical case: patient treated for vulvovaginal candidiasis

open access: yesКлинический разбор в общей медицине, 2021
Case study of acute vulvovaginal candidiasis treated with medication containing dequalinium chloride as an active ingredient has been reported. Patient A.
Tatyana Yu. Pestrikova
doaj   +1 more source

Candida albicans pathogenicity mechanisms [PDF]

open access: yes, 2013
Peer reviewedPublisher ...
Alonso-Monge R   +10 more
core   +1 more source

A tale of two yeasts : Saccharomyces cerevisiae as a therapeutic against candidiasis [PDF]

open access: yes, 2016
Funding DW is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (102549/Z/13/Z), a Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology (097377/Z/11/Z), the MRC and University of ...
Wilson, Duncan
core   +1 more source

Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy [PDF]

open access: yesРМЖ. Мать и дитя, 2018
Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.
Kan N.E., Lomova N.A., Kokoeva D.N.
doaj  

Topical treatment for acute vulvovaginal candidiasis [PDF]

open access: yesРМЖ. Мать и дитя, 2019
Topical treatment for acute vulvovaginal candidiasis V.G. Volkov Tula State University, Tula, Russian Federation Vulvovaginal candidiasis is a yeast infection of vulvar and vaginal mucosa caused by Candida species.
Volkov V.G.
doaj  

Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj   +1 more source

Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment

open access: yesМедицинский совет, 2019
The article represents the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). It is noted that C. albicans causes candidiasis in 75-80% of cases.
N. A. Buralkina, O. V. Shabalova
doaj   +1 more source

Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy